Quantification of Genotoxic Impurities by HPLC in Active Pharmaceutical Ingredient Lorazepam

被引：0
|
作者：
Panga Chinna
Shet Prakash M.
Ramesha Andagar Ramakrishna
Swamy Sreenivasa
Yashbir Singh
机构：
[1] Department of Studies and Research in Chemistry,
[2] Tumkur University,undefined
[3] RL Fine Chem Pvt Ltd,undefined
[4] Department of Chemistry,undefined
[5] University College of Science,undefined
[6] Tumkur University,undefined
[7] National Assessment and Accreditation Council,undefined
来源：
Journal of Analytical Chemistry | 2023年 / 78卷
关键词：
genotoxic impurity; validation; lorazepam; high performance liquid chromatography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：514 / 521
页数：7
相关论文
共 50 条
  • [41] A perspective on testing of existing pharmaceutical excipients for genotoxic impurities
    Brusick, David J.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2009, 55 (02) : 200 - 204
  • [42] Genotoxic Impurities in Pharmaceutical Manufacturing: Sources, Regulations, and Mitigation
    Szekely, Gyorgy
    Amores de Sousa, Miriam C.
    Gil, Marco
    Ferreira, Frederico Castelo
    Heggie, William
    CHEMICAL REVIEWS, 2015, 115 (16) : 8182 - 8229
  • [43] The determination of two analogues of 4-(azidomethyl)-1,1′-biphenyl as potential genotoxic impurities in the active pharmaceutical ingredient of several sartans containing a tetrazole group
    Jires, Jakub
    Gibala, Petr
    Kalasek, Stanislav
    Dousa, Michal
    Doubsky, Jan
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 205
  • [44] Development and validation of an analytical method for quantification of potential genotoxic impurity 4-dimethylaminopyridine in linagliptin active pharmaceutical ingredient using Hydrophilic Interaction Liquid Chromatography
    Al-Sabti, Bashar
    Harbali, Jehad
    SEPARATION SCIENCE PLUS, 2020, 3 (09) : 399 - 406
  • [45] Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient
    Thomas, Saji
    Shandilya, Sanjeev
    Bharati, Amber
    Paul, Saroj Kumar
    Agarwal, Ashutosh
    Mathela, Chandra S.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 57 : 39 - 51
  • [46] Regulatory Submission Templates for Elemental Impurities, Genotoxic Impurities, and Nitrosamine Impurities of Pharmaceutical Drug Substances
    Nilesh, Patil
    Sandeep, Patel
    Dave, Hiral
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2024, 16 (04) : 366 - 377
  • [47] Validated Stability Indicating HPLC Method for the Quantification of Process Related Impurities of Ubrogepant in Pharmaceutical Formulations
    Nagababu, Uppu
    Sujatha, D.
    Jyothi, Uppalapati
    Vissa, Manikyala Rao
    Kumar, B. Srinivasa
    EURASIAN JOURNAL OF CHEMISTRY, 2023, 109 (01): : 31 - 40
  • [48] Development and Validation of Genotoxic Impurity in Esomeprazole Magnesium Trihydrate Active Pharmaceutical Ingredient by LC-MS/MS
    Yelampalli, Suresh Reddy
    Jagarlapudi, Venkata Shanmukha Kumar
    Mallu, Useni Reddy
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2019, 53 (04) : S642 - S649
  • [49] Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction
    Cooper, VB
    Pearce, GES
    Petts, CR
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (09) : 1323 - 1329
  • [50] Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development
    Iliou, Katerina
    Malenovic, Andelija
    Loukas, Yannis L.
    Dotsikas, Yannis
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 149 : 410 - 418
12345